|
Figure 6 Immunocytochemistry Validation of Caspase 9 in HeLa CellsImmunocytochemical analysis of HeLa cells using anti-Caspase 9 antibody (2073) at 5 &956,g/ml. Cells was fixed with formaldehyde and blocked with 10% serum for 1 h at RT, antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4&730,C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin. |
|
Figure 4 Immunofluorescence Validation of Caspase 9 in K562 CellsImmunofluorescent analysis of 4% paraformaldehyde-fixed K562 cells labeling Caspase 9 with 2073 at 20 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green). |
|
Figure 5 Immunofluorescence Validation of Caspase 9 in HeLa CellsImmunofluorescent analysis of 4% paraformaldehyde-fixed HeLa cells labeling Caspase 9 with 2073 at 5 &956,g/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI staining (blue). |
|
Figure 1 Independent Antibody Validation (IAV) via Protein Expression Profile in Human Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: Caspase 9, 2071 (1 &956,g/mL), Caspase 9, 2073 (1 &956,g/mL) and beta-actin (1.5 &956,g/mL), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |
|
Figure 2 Western Blot Validation in Human Cell LinesLoading: 15 &956,g of lysates per lane.Antibodies: : Caspase 9, 2073 (1 &956,g/mL)), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |
|
Figure 3 Western Blot Validation in Mouse Cell LineLoading: 15 &956,g of 3T3/NIH cell lysate.Antibodies: : Caspase 9, 2073 (1 &956,g/mL)), 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution. |